cefuroxime has been researched along with Immunologic Deficiency Syndromes in 1 studies
Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.
Immunologic Deficiency Syndromes: Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Rödjer, S | 1 |
Alestig, K | 1 |
Bergmark, J | 1 |
Bergström, T | 1 |
Hultberg, B | 1 |
Jagenburg, R | 1 |
Olaisson, L | 1 |
Trollfors, B | 1 |
Westin, J | 1 |
1 trial available for cefuroxime and Immunologic Deficiency Syndromes
Article | Year |
---|---|
Treatment of septicaemia in immunocompromised patients with ceftazidime or with tobramycin and cefuroxime, with special reference to renal effects.
Topics: Adult; Aged; Ceftazidime; Cefuroxime; Female; Humans; Immunologic Deficiency Syndromes; Kidney; Kidn | 1987 |